Research
Integrative cancer research in digestive oncology : M. Ychou/A. Thierry

Publications

Viala M, Vinches M, Alexandre M, Mollevi C, Durigova A, Hayaoui N, et al. Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection. Br J Cancer. 6 mars 2018;118(5):679?97.

 

Van Cutsem E, Martinelli E, Cascinu S, Sobrero A, Banzi M, Seitz J-F, et al. Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study. Oncologist. 6 sept 2018;

 

 Tosi D, Pérez-Gracia E, Atis S, Vié N, Combès E, Gabanou M, et al. Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment. BMC Cancer. 13 août 2018;18(1):812.

 

Thierry AR, Tanos R. [Liquid biopsy: a possible approach for cancer screening]. Med Sci (Paris). oct 2018;34(10):824?32.

Thierry AR. A Step Closer to Cancer Screening by Blood Test. Clin Chem. oct 2018;64(10):1420?2.

 

Tapi Nzali MD, Aze J, Bringay S, Lavergne C, Mollevi C, Optiz T. Reconciliation of patient/doctor vocabulary in a structured resource. Health Informatics J. 1 janv 2018;1460458217751014.

 

Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy P-J, Assou S, et al. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Sci Rep. 29 oct 2018;8(1):15931.

 

Sanchez C, Snyder MW, Tanos R, Shendure J, Thierry AR. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis. npj Genomic Medicine [Internet]. déc 2018 [cité 29 nov 2018];3(1).

 

Quénet F, Pissas M-H, Gil H, Roca L, Carrère S, Sgarbura O, et al. Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery. 16 nov 2018;

 

Piton N, Ruminy P, Gravet C, Marchand V, Colasse É, Lamy A, et al. Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinoma. Lab Invest. mars 2018;98(3):371?9.

 

Péron J, Mercier F, Tuech J-J, Younan R, Sideris L, Gelli M, et al. The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis. Surgery. 6 sept 2018;

 

Pannier D, Adenis A, Bogart E, Dansin E, Clisant-Delaine S, Decoupigny E, et al. Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial. BMC Cancer. 31 juill 2018;18(1):775.

 

Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, et al. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. 1 août 2018;110(8):888?94.

 

Ousmen A, Touraine C, Deliu N, Cottone F, Bonnetain F, Efficace F, et al. Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. Health Qual Life Outcomes. 11 déc 2018;16(1):228.

 

Nougaret S, Lakhman Y, Molinari N, Feier D, Scelzo C, Vargas HA, et al. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol. avr 2018;210(4):918?26.

 

Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, et al. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol. 11 juill 2018;

 

Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. Ovarian cancer: An update on imaging in the era of radiomics. Diagn Interv Imaging. 13 déc 2018;

 

Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, et al. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. 2018;67(6):1095?102.

 

 

 

Mariette C, Renaud F, Piessen G, Gele P, Copin M-C, Leteurtre E, et al. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. BMC Cancer. 06 2018;18(1):139.

 

Marcos E, Nougaret S, Tsujimoto S, Genovesio A. Outcome Modulation Across Tasks in the Primate Dorsolateral Prefrontal Cortex. Neuroscience. 10 2018;371:96?105.

 

Kubik-Huch RA, Weston M, Nougaret S, Leonhardt H, Thomassin-Naggara I, Horta M, et al. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas. Eur Radiol. août 2018;28(8):3125?37.

 

Khier S, Lohan L. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature. Future Sci OA. avr 2018;4(4):FSO295.

 

Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, et al. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Mol Med. avr 2018;10(4).

 

Hutt E, Da Silva A, Bogart E, Le Lay-Diomande S, Pannier D, Delaine-Clisant S, et al. Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial. BMJ Open. 23 2018;8(1):e015904.

 

Guiu S, Mollevi C, Charon-Barra C, Boissière F, Crapez E, Chartron E, et al. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers. Br J Cancer. juill 2018;119(1):76?9.

 

Grimaldi M, Boulahtouf A, Prévostel C, Thierry A, Balaguer P, Blache P. A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway. Front Pharmacol. 2018;9:1160.

 

Gollub MJ, Arya S, Beets-Tan RG, dePrisco G, Gonen M, Jhaveri K, et al. Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY). nov 2018;43(11):2893?902.

 

Fiteni F, Favier M, Bascoul-Mollevi C, Gourgou S, Cousin C, Houédé N. [Impacts of routine patient-reported-outcomes monitoring in oncology]. Bull Cancer. sept 2018;105(9):847?8.

 

Escal L, Nougaret S, Guiu B, Bertrand MM, de Forges H, Tetreau R, et al. MRI-based score to predict surgical difficulty in patients with rectal cancer. Br J Surg. janv 2018;105(1):140?6.

 

Decraene C, Silveira AB, Bidard F-C, Vallée A, Michel M, Melaabi S, et al. Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clin Chem. févr 2018;64(2):317?28.

 

Corines MJ, Nougaret S, Weiser MR, Khan M, Gollub MJ. Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis Colon Rectum. févr 2018;61(2):193?201.

 

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul J-L, et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 20 2018;379(25):2395?406.

 

Cohen R, Hain E, Buhard O, Guilloux A, Bardier A, Kaci R, et al. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status. JAMA Oncol. 15 nov 2018;

 

Bennouna J, Hiret S, Bertaut A, Bouché O, Deplanque G, Borel C, et al. Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial. JAMA Oncol. 25 oct 2018;

 

Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F, et al. Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Programs Biomed. mai 2018;158:153?9.

 

Barbieri A, Tami M, Bry X, Azria D, Gourgou S, Bascoul-Mollevi C, et al. EM algorithm estimation of a structural equation model for the longitudinal study of the quality of life. Stat Med. 15 mars 2018;37(6):1031?46.

 

.

 


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés